Pfizer Inc
-
Health News
If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
[ad_1] Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk…
Read More » -
Business
Pfizer shares fall as 2024 revenue and profit forecast disappoints
[ad_1] Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it…
Read More » -
Business
Free ChatGPT may incorrectly answer drug questions, study says
[ad_1] Harun Ozalp | Anadolu | Getty Images The free version of ChatGPT may provide inaccurate or incomplete responses —…
Read More » -
Business
Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined…
Read More » -
Health News
Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly
[ad_1] Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news…
Read More » -
Business
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
[ad_1] Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese…
Read More » -
Health News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
[ad_1] Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021.…
Read More » -
Business
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
[ad_1] A sign advertises Covid vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, on Aug. 14, 2023. Brian Snyder…
Read More » -
Pics News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
[ad_1] CFOTO | Future Publishing | Getty Images As its Covid gains evaporate, Pfizer wants a chunk of the budding…
Read More »